Norepinephrine efflux evoked by potassium chloride in cat sympathetic nerves: dual mechanism of action

被引:15
作者
Yamazaki, T
Akiyama, T
Kawada, T
Kitagawa, H
Takauchi, Y
Yahagi, N
Sunagawa, K
机构
[1] Natl Cardiovasc Ctr, Res Inst, Dept Cardiac Physiol, Suita, Osaka 565, Japan
[2] Natl Cardiovasc Ctr, Res Inst, Dept Cardiovasc Dynam, Suita, Osaka 565, Japan
关键词
calcium channel; omega-conotoxin GVIA; desipramine; exocytosis; neurotransporter; noradrenaline;
D O I
10.1016/S0006-8993(98)00209-1
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Using a dialysis technique, prominent efflux of norepinephrine (NE) from cardiac sympathetic nerve endings was observed under local administration of potassium chloride (KCl, 100 mM). KCl induced NE efflux was suppressed by omega-conotoxin GVIA or desipramine but residual efflux of NE was still detectable. In the presence of omega-conotoxin GVIA, KCl induced efflux of NE was augmented by pretreatment with reserpine, indicating that this efflux of NE was derived from axoplasma with neurotransporter. These data suggest that a KCl induced brisk increase in dialysate NE levels might occur as a consequence of exocytotic NE release and carrier mediated outward NE transport from nerve endings. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 25 条
[1]   INVIVO MONITORING OF MYOCARDIAL INTERSTITIAL NOREPINEPHRINE BY DIALYSIS TECHNIQUE [J].
AKIYAMA, T ;
YAMAZAKI, T ;
NINOMIYA, I .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (05) :H1643-H1647
[2]  
BADOER E, 1989, N-S ARCH PHARMACOL, V339, P54
[3]  
BONISCH H, 1988, HDB EXPT PHARM, V90, P246
[4]   COMPARATIVE RESPONSES OF BRAIN-STEM AND HIPPOCAMPAL-NEURONS TO O-2 DEPRIVATION - INVITRO INTRACELLULAR STUDIES [J].
DONNELLY, DF ;
JIANG, C ;
HADDAD, GG .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (05) :L549-L554
[5]  
ELDIN MMM, 1987, J PHARMACOL EXP THER, V243, P7685
[6]   O-2 DEPRIVATION IN THE CENTRAL-NERVOUS-SYSTEM - ON MECHANISMS OF NEURONAL RESPONSE, DIFFERENTIAL SENSITIVITY AND INJURY [J].
HADDAD, GG ;
JIANG, C .
PROGRESS IN NEUROBIOLOGY, 1993, 40 (03) :277-318
[7]  
KATSURAGI T, 1988, J PHARMACOL EXP THER, V247, P302
[8]  
KOPIN IJ, 1985, PHARM REV, V37
[9]  
KRANZHOFER R, 1991, CIRC RES, V68
[10]  
PARKER EM, 1988, J PHARM EXP THER, V245